Dyslipidemias in critically ill patients with sepsis and septic shock

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015315

Enrollment

124

Registered

2019-01-14

Start date

2018-05-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A41.9

Interventions

Group 1: Observational study: In septic patients admitted to the ICU, medical history, clinical parameters, lipid parameters, medication and nutrition are assesed on study days 0, 3, 7 and 14. The stu

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years, Sepsis or septic shock as defined by sepsis-3-criteria (suspected infection and rise in SOFA-score >=2), Admission to the ICU

Exclusion criteria

Exclusion criteria: Palliative care, comfort terminal care, AIDS, pregnancy, Age > 100 years

Design outcomes

Primary

Measure	Time frame
There will be two primary outcome variables: 1. prevalence of dyslipidemia in sepsis and septic shock 2. 28-day mortality	—

Secondary

Measure	Time frame
1. correlation of dyslipidemia with 28-day mortality 2. correlation of dyslipidemia with SOFA score 3. correlation of dyslipidemia with inflammatory parameters 4. correlation of dyslipidemia with enteral/parenteral nutrition 5. correlation of dyslipidemia with medication (i.e. propofol)	—

Countries

Austria

Contacts

Public ContactPhilipp Eller

Universitätsklinik für Innere Medizin, Medizinische Universität Graz

philipp.eller@medunigraz.at+4331638580176

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026